Event Date/Time: Apr 06, 2011
End Date/Time: Apr 06, 2011
Vaccine development involves a multitude of challenges from both scientific and business perspectives; progressing a new vaccine through this lengthy process can be overly time consuming and expensive if not approached in the right way. This masterclass shall utilise the specific case study of Sanofi-Pasteurâ€™s dengue fever vaccine development currently in phase III. Learn from analysing clinical and preclinical evaluations with Dr. Jean Lang, who will also cover region specific regulatory environments and risk management considerations in this unmissable class.